Last Updated:

Sunday, May 19, 2024

7:01 PM

Canada

Algernon Pharmaceuticals

Algernon Pharmaceuticals is a clinical-stage pharmaceutical development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), inflammatory bowel disease (IBD) and idiopathic pulmonary fibrosis (IPF).

Algernon Pharmaceuticals is a clinical-stage pharmaceutical development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), inflammatory bowel disease (IBD) and idiopathic pulmonary fibrosis (IPF).

Newsroom